151 related articles for article (PubMed ID: 36930254)
21. Understanding variation in primary prostate cancer treatment within the Veterans Health Administration.
Nambudiri VE; Landrum MB; Lamont EB; McNeil BJ; Bozeman SR; Freedland SJ; Keating NL
Urology; 2012 Mar; 79(3):537-45. PubMed ID: 22245306
[TBL] [Abstract][Full Text] [Related]
22. High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Review.
Chaussy CG; Thüroff S
J Endourol; 2017 Apr; 31(S1):S30-S37. PubMed ID: 28355119
[TBL] [Abstract][Full Text] [Related]
23. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
24. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
[TBL] [Abstract][Full Text] [Related]
25. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
26. Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.
Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani AB; Kucuk ON; Master VA; Gillespie TW; Filson CP
Urol Oncol; 2017 May; 35(5):250-256. PubMed ID: 28089387
[TBL] [Abstract][Full Text] [Related]
27. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
28. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.
Bacchetta F; Martins M; Regusci S; Jichlinski P; Meuwly JY; Lucca I; Valerio M
Urol Oncol; 2020 Nov; 38(11):846.e1-846.e7. PubMed ID: 32532530
[TBL] [Abstract][Full Text] [Related]
29. [Clinical, morphological and microcirculatory criteria of local recurrence of the prostate cancer after HIFU therapy].
Neymark AI; Tachalov MA; Neymark BA; Levin VP
Urologiia; 2020 Jun; (3):69-76. PubMed ID: 32597589
[TBL] [Abstract][Full Text] [Related]
30. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
31. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
32. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
Hamdy FC; Elliott D; le Conte S; Davies LC; Burns RM; Thomson C; Gray R; Wolstenholme J; Donovan JL; Fitzpatrick R; Verrill C; Gleeson F; Singh S; Rosario D; Catto JW; Brewster S; Dudderidge T; Hindley R; Emara A; Sooriakumaran P; Ahmed HU; Leslie TA
Health Technol Assess; 2018 Sep; 22(52):1-96. PubMed ID: 30264692
[TBL] [Abstract][Full Text] [Related]
33. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
Reddy D; van Son M; Peters M; Bertoncelli Tanaka M; Dudderidge T; Cullen E; Ho CLT; Hindley RG; Emara A; McCracken S; Orczyk C; Shergill I; Mangar S; Nigam R; Virdi J; Moore CM; Arya M; Shah TT; Winkler M; Emberton M; Falconer A; Belsey J; Ahmed HU
J Med Econ; 2023; 26(1):1099-1107. PubMed ID: 37656223
[TBL] [Abstract][Full Text] [Related]
34. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.
Amini A; Raben D; Crawford ED; Flaig TW; Kessler ER; Lam ET; Maroni P; Pugh TJ
Urol Oncol; 2017 Jun; 35(6):438-446. PubMed ID: 28214281
[TBL] [Abstract][Full Text] [Related]
35. Ablative Focused Ultrasound Synergistically Enhances Thermally Triggered Chemotherapy for Prostate Cancer in Vitro.
Arora JS; Murad HY; Ashe S; Halliburton G; Yu H; He J; John VT; Khismatullin DB
Mol Pharm; 2016 Sep; 13(9):3080-90. PubMed ID: 27383214
[TBL] [Abstract][Full Text] [Related]
36. Cementless Fixation Is Associated With Increased Risk of Early and All-Time Revision After Hemiarthroplasty But Not After THA for Femoral Neck Fracture: Results From the American Joint Replacement Registry.
Huddleston JI; De A; Jaffri H; Barrington JW; Duwelius PJ; Springer BD
Clin Orthop Relat Res; 2021 Oct; 479(10):2194-2202. PubMed ID: 34398846
[TBL] [Abstract][Full Text] [Related]
37. Local Therapy Improves Overall Survival in Patients With Newly Diagnosed Metastatic Prostate Cancer.
Parikh RR; Byun J; Goyal S; Kim IY
Prostate; 2017 May; 77(6):559-572. PubMed ID: 28093791
[TBL] [Abstract][Full Text] [Related]
38. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
39. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One].
Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY
Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710
[TBL] [Abstract][Full Text] [Related]
40. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
Scales CD; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ;
J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
